Functional Neuromodulation Inc. is dedicated to advancing the application of deep brain stimulation to help improve the lives of people with Alzheimer's disease and other memory and cognitive disorders.

Stimulating the Brain's Memory Circuits —
Investigating A New Approach to Alzheimer's

Functional Neuromodulation Ltd. is investigating the use of deep brain stimulation of the fornix (DBS-f) to drive neural activity and modulate the brain's memory circuit. The company has raised a total of $13.4 in funding commitments from Genesys Capital, Foundation Medical Partners and Medtronic, Inc.   Building on early clinical data, the company has initiated the ADvance Study, a multi-center feasibility study of DBS-f in patients with mild Alzheimer’s.  LEARN MORE

 

OUR APPROACH Deep brain stimulation (DBS) uses a surgically implanted medical device, similar to a cardiac pacemaker, to deliver mild electrical pulses to precisely targeted areas of the brain. Functional Neuromodulation is advancing DBS of the fornix in the treatment of Alzheimer's. The fornix is a major inflow and output pathway in the brain's memory circuit that has been shown to be one of the first areas of the brain affected by Alzheimer's.. Learn More

ABOUT ALZHEIMER'S DISEASE Alzheimer's is a progressively debilitating disease that slowly destroys memory and thinking skills, ultimately resulting in death. Alzheimer's is the most common cause of dementia among older persons, affecting 13% over age 64 and nearly 50% over 85. Learn More